Cargando…
Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521222/ https://www.ncbi.nlm.nih.gov/pubmed/35770533 http://dx.doi.org/10.3324/haematol.2022.281214 |
_version_ | 1784799794947948544 |
---|---|
author | Gangat, Naseema Johnson, Isla McCullough, Kristen Farrukh, Faiqa Al-Kali, Aref Alkhateeb, Hassan Begna, Kebede Mangaonkar, Abhishek Litzow, Mark Hogan, William Shah, Mithun Patnaik, Mrinal Pardanani, Animesh Tefferi, Ayalew |
author_facet | Gangat, Naseema Johnson, Isla McCullough, Kristen Farrukh, Faiqa Al-Kali, Aref Alkhateeb, Hassan Begna, Kebede Mangaonkar, Abhishek Litzow, Mark Hogan, William Shah, Mithun Patnaik, Mrinal Pardanani, Animesh Tefferi, Ayalew |
author_sort | Gangat, Naseema |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9521222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-95212222022-10-24 Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia Gangat, Naseema Johnson, Isla McCullough, Kristen Farrukh, Faiqa Al-Kali, Aref Alkhateeb, Hassan Begna, Kebede Mangaonkar, Abhishek Litzow, Mark Hogan, William Shah, Mithun Patnaik, Mrinal Pardanani, Animesh Tefferi, Ayalew Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-06-30 /pmc/articles/PMC9521222/ /pubmed/35770533 http://dx.doi.org/10.3324/haematol.2022.281214 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Letter to the Editor Gangat, Naseema Johnson, Isla McCullough, Kristen Farrukh, Faiqa Al-Kali, Aref Alkhateeb, Hassan Begna, Kebede Mangaonkar, Abhishek Litzow, Mark Hogan, William Shah, Mithun Patnaik, Mrinal Pardanani, Animesh Tefferi, Ayalew Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia |
title | Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia |
title_full | Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia |
title_fullStr | Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia |
title_full_unstemmed | Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia |
title_short | Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia |
title_sort | molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521222/ https://www.ncbi.nlm.nih.gov/pubmed/35770533 http://dx.doi.org/10.3324/haematol.2022.281214 |
work_keys_str_mv | AT gangatnaseema molecularpredictorsofresponsetovenetoclaxplushypomethylatingagentintreatmentnaiveacutemyeloidleukemia AT johnsonisla molecularpredictorsofresponsetovenetoclaxplushypomethylatingagentintreatmentnaiveacutemyeloidleukemia AT mcculloughkristen molecularpredictorsofresponsetovenetoclaxplushypomethylatingagentintreatmentnaiveacutemyeloidleukemia AT farrukhfaiqa molecularpredictorsofresponsetovenetoclaxplushypomethylatingagentintreatmentnaiveacutemyeloidleukemia AT alkaliaref molecularpredictorsofresponsetovenetoclaxplushypomethylatingagentintreatmentnaiveacutemyeloidleukemia AT alkhateebhassan molecularpredictorsofresponsetovenetoclaxplushypomethylatingagentintreatmentnaiveacutemyeloidleukemia AT begnakebede molecularpredictorsofresponsetovenetoclaxplushypomethylatingagentintreatmentnaiveacutemyeloidleukemia AT mangaonkarabhishek molecularpredictorsofresponsetovenetoclaxplushypomethylatingagentintreatmentnaiveacutemyeloidleukemia AT litzowmark molecularpredictorsofresponsetovenetoclaxplushypomethylatingagentintreatmentnaiveacutemyeloidleukemia AT hoganwilliam molecularpredictorsofresponsetovenetoclaxplushypomethylatingagentintreatmentnaiveacutemyeloidleukemia AT shahmithun molecularpredictorsofresponsetovenetoclaxplushypomethylatingagentintreatmentnaiveacutemyeloidleukemia AT patnaikmrinal molecularpredictorsofresponsetovenetoclaxplushypomethylatingagentintreatmentnaiveacutemyeloidleukemia AT pardananianimesh molecularpredictorsofresponsetovenetoclaxplushypomethylatingagentintreatmentnaiveacutemyeloidleukemia AT tefferiayalew molecularpredictorsofresponsetovenetoclaxplushypomethylatingagentintreatmentnaiveacutemyeloidleukemia |